These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24268548)

  • 1. Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).
    Lions C; Carrieri MP; Michel L; Mora M; Marcellin F; Morel A; Spire B; Roux P;
    Drug Alcohol Depend; 2014 Feb; 135():1-8. PubMed ID: 24268548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians.
    Roux P; Lions C; Michel L; Cohen J; Mora M; Marcellin F; Spire B; Morel A; Carrieri PM; Karila L;
    Curr Pharm Des; 2014; 20(25):4097-105. PubMed ID: 24001291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone induction in primary care for opioid dependence: a pragmatic randomized trial (ANRS Methaville).
    Carrieri PM; Michel L; Lions C; Cohen J; Vray M; Mora M; Marcellin F; Spire B; Morel A; Roux P;
    PLoS One; 2014; 9(11):e112328. PubMed ID: 25393311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
    Roux P; Lions C; Vilotitch A; Michel L; Mora M; Maradan G; Marcellin F; Spire B; Morel A; Carrieri PM;
    Harm Reduct J; 2016 Apr; 13():12. PubMed ID: 27048152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.
    Roux P; Michel L; Cohen J; Mora M; Morel A; Aubertin JF; Desenclos JC; Spire B; Carrieri PM;
    BMC Public Health; 2012 Jun; 12():488. PubMed ID: 22741944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).
    Salsitz EA; Joseph H; Frank B; Perez J; Richman BL; Salomon N; Kalin MF; Novick DM
    Mt Sinai J Med; 2000; 67(5-6):388-97. PubMed ID: 11064489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme.
    Tjagvad C; Skurtveit S; Linnet K; Andersen LV; Christoffersen DJ; Clausen T
    Eur Addict Res; 2016; 22(5):249-58. PubMed ID: 27246839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
    Nordmann S; Lions C; Vilotitch A; Michel L; Mora M; Spire B; Maradan G; Morel A; Roux P; Carrieri MP;
    Psychopharmacology (Berl); 2016 Apr; 233(7):1203-13. PubMed ID: 26753792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of gabapentin on methadone based addiction treatment: a randomized controlled trial.
    Moghadam MS; Alavinia M
    Pak J Pharm Sci; 2013 Sep; 26(5):985-9. PubMed ID: 24035957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment.
    Sell L; Zador D
    Addiction; 2004 Apr; 99(4):442-9. PubMed ID: 15049744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom complaints of patients prescribed either oral methadone or injectable heroin.
    Dürsteler-MacFarland KM; Fischer DA; Mueller S; Schmid O; Moldovanyi A; Wiesbeck GA
    J Subst Abuse Treat; 2010 Jun; 38(4):328-37. PubMed ID: 20206457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy.
    Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M
    Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.